Assessment of dyspneic sensation in patients with type 2 diabetes

Other authors

Institut Català de la Salut

[Mizab C, Gutiérrez-Carrasquilla L] Endocrinology and Nutrition Department, University Hospital Sant Joan de Reus, Reus, Spain. [Sánchez E] Endocrinology and Nutrition Department, University Hospital Arnau de Vilanova, Lleida, Spain. Obesity, Diabetes and Metabolism (ODIM) Research Group, Institut de Recerca Biomèdica de Lleida (IRBLleida), Lleida, Spain. Medicine and Surgery Department, University of Lleida, Lleida, Spain. [Balsells N, Arqué A] Endocrinology and Nutrition Department, University Hospital Arnau de Vilanova, Lleida, Spain. [Ruano R] Endocrinology and Nutrition Department, University Hospital Arnau de Vilanova, Lleida, Spain. Obesity, Diabetes and Metabolism (ODIM) Research Group, Institut de Recerca Biomèdica de Lleida (IRBLleida), Lleida, Spain. [Hernández C, Simó R] Servei d’Endocrinologia i Nutrició, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca en Diabetis i Metabolisme, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain

Vall d'Hebron Barcelona Hospital Campus

Publication date

2023-09-04T12:26:34Z

2023-09-04T12:26:34Z

2023-08-10



Abstract

Diabetes complications; Questionnaires; Respiratory symptoms


Complicaciones de la diabetes; Questionarios; Síntomas respiratorios


Complicacions de la diabetis; Qüestionaris; Símptomes respiratoris


Introduction: Individuals with type 2 diabetes (T2D) should be considered a susceptible group for pulmonary dysfunction. So, we aimed to evaluate the sensation of breathlessness in this population by administering two well-validated questionnaires. Methods: This is a crosssectional study with 592 people without known respiratory disease (353 with T2D) who answered the modified Medical Research Council (mMRC) questionnaire. In addition, 47% also responded to the St George Respiratory Questionnaire, a specific instrument designed to be applied to patients with obstructive airway disease. Results: Patients with T2D showed a higher mMRC score in comparison to the control group [1.0 (0.0 – 4.0) vs. 0.0 (0.0 – 4.0), p<0.001]. A higher prevalence of subjects with mMRC ≥2 was observed in T2D that in the control group (20.2% vs. 11.6%, p=0.004). Participants with T2D and mMRC ≥2 showed a higher HbA1c (8.2 ± 1.6% vs. 7.8 ± 1.6%, p=0.048), longer T2D evolution and higher prevalence of nephropathy. In the multivariate analysis, the presence of T2D [OR=1.95 (1.19 to 3.22), p=0.008] in all the population, and HbA1c [OR=1.19 (1.01 to 1.41), p=0.034] and the presence of diabetic nephropathy [OR=2.00 (1.14 to 3.52), p=0.015] in patients with T2D, predicted a mMRC ≥2. Finally, no differences were observed regarding the SGRQ score among groups. Conclusions: Patients with T2D showed a greater sensation of dyspnea than subjects with normal carbohydrate metabolism. Risk factors included poor metabolic control and the presence of renal disease.


This research was supported by grants from Instituto de Salud Carlos III (PI15/00260), Fondos FEDER “Una manera de hacer Europa”), and Sociedad Española de Endocrinología y Nutrición. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM) is an initiative of the Instituto Carlos III.

Document Type

Article


Published version

Language

English

Publisher

Frontiers Media

Related items

Frontiers in Endocrinology;14

https://doi.org/10.3389/fendo.2023.1208020

Recommended citation

This citation was generated automatically.

Rights

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

This item appears in the following Collection(s)